20Nov 2024
Betamethasone Injections Show Promise for Chronic Prostatitis Symptom Relief

Betamethasone Injections Show Promise for Chronic Prostatitis Symptom Relief

The prospective cohort clinical trial evaluated the safety and efficacy of TRUS-guided intraprostatic betamethasone injections in 45 patients with refractory chronic nonbacterial prostatitis (CNP). Six injections were administered, and outcomes were assessed using NIH-CPSI, IPSS, IIEF, GRA, and VAS at 1, 4, and 12 weeks post-injection. Pain and urinary symptoms significantly improved, with 71% of patients achieving success (≥25% symptom reduction) on the NIH-CPSI at 1 week, dropping to 55.6% and 44.4% at 4 and 12 weeks, respectively. The GRA scores indicated successful pain control in 82%, 71%, and 64.4% at the same intervals. Improvements in IPSS and IIEF scores were observed but modest. These findings suggest that intraprostatic betamethasone injections are a simple, safe, and effective option for managing refractory CNP with predominant pain and urinary symptoms.

  • #urology

Like

Save

Share